Identification and Mapping of a Common Proviral Integration Site Fli-1 in Erythroleukemia Cells Induced by Friend Murine Leukemia Virus
Overview
Authors
Affiliations
Friend murine leukemia virus (F-MuLV) induces erythroleukemia when inoculated into newborn BALB/c or NIH/Swiss mice. We have molecularly cloned F-MuLV host cell DNA junction fragments from an erythroleukemia cell line induced by F-MuLV to identify cellular genes involved in the leukemogenic process. One particular proviral integration site, Fli-1, is rearranged in 75% (9/12) of independently isolated erythroleukemia cell lines derived from either BALB/c or NIH/Swiss mice inoculated at birth with F-MuLV. Other hematopoietic neoplasms induced by F-MuLV, including myeloid (granulocytic) and lymphoid tumors, did not show rearrangements of the Fli-1 locus. Similarly, none of 35 erythroleukemia cell lines induced by the Friend virus complexes (FV-A and FV-P) was rearranged at the Fli-1 locus. In contrast, no rearrangements were detected at the Sfpi-1 locus, a preferred site of integration in either FV-P- or FV-A-induced leukemias. Using recombinant inbred mice, the Fli-1 locus was situated on mouse chromosome 9 close to the cellular protooncogene c-ets-1. DNA and RNA analysis suggests, however, that Fli-1 is different from ets-1. Thus, Fli-1 appears to define a distinct locus specifically involved in the induction of erythroid leukemias by F-MuLV.
Yu K, Tang Y, Wang C, Liu W, Hu M, Hu A Int J Mol Sci. 2025; 25(24.
PMID: 39769192 PMC: 11676164. DOI: 10.3390/ijms252413426.
Wang H, Lau S, Tan A, Tang F Cells. 2024; 13(20.
PMID: 39451223 PMC: 11505968. DOI: 10.3390/cells13201705.
FLI-1-driven regulation of endothelial cells in human diseases.
Zhang L, Ge T, Cui J J Transl Med. 2024; 22(1):740.
PMID: 39107790 PMC: 11302838. DOI: 10.1186/s12967-024-05546-4.
Wang C, Hu M, Yu K, Liu W, Hu A, Kuang Y Mol Med Rep. 2024; 29(6).
PMID: 38695236 PMC: 11082641. DOI: 10.3892/mmr.2024.13231.
FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.
Wang J, Wang C, Hu A, Yu K, Kuang Y, Gajendran B BMC Cancer. 2024; 24(1):326.
PMID: 38461240 PMC: 10925000. DOI: 10.1186/s12885-024-12075-2.